On March 28th 2013, Winteam closed at HKD 3.54 per share, created the new high record of its stock price since 4PM, February 28th 2013, when the tender offer of Winteam Pharmaceutical Group by SINOPHARM successfully completed, that fully reflected the capital market’s confidence in the future of the company.
After completion of the acquisition, Sinopharm TCM holds a 56.97% stake of Winteam Group through its wholly owned subsidiary in Hong Kong.
The successful acquisition of Winteam Group is an important measures to speed up the development of modern Chinese traditional medicine business in SINOPHARM. Afterwards, it will make full use of Winteam Group’s good industrial base, with the listed company capital platform, to promote rapid development of proprietary Chinese medicine industry.
[Reported by Department of Investment Management, SINOPHARM]